|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123.00 INR | -0.08% |
|
-0.69% | +71.09% |
| 05-21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| 05-20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.59B 69.18M 60.47M 55.58M 51.8M 98.25M 99.74M 667M 259M 3.24B 260M 254M 11.16B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 7.45B 78.24M 68.4M 62.86M 58.59M 111M 113M 755M 293M 3.66B 294M 287M 12.62B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.65% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -0.08% | ||
| 1 week | -0.69% | ||
| Current month | -1.05% | ||
| 1 month | +17.70% | ||
| 3 months | +84.49% | ||
| 6 months | +75.34% | ||
| Current year | +71.09% |
| 1 week | 122.5 | 126 | |
| 1 month | 103.45 | 133.95 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.08% | -0.69% | +11.11% | +14.47% | 69.18M | ||
| +1.81% | +2.25% | +13.63% | +82.33% | 48B | ||
| +2.12% | +5.91% | +71.67% | +116.91% | 36.89B | ||
| +0.15% | +1.26% | -3.64% | +44.26% | 12.37B | ||
| +3.71% | +3.56% | +13.95% | +94.97% | 11.95B | ||
| +0.39% | +0.58% | +32.90% | +119.07% | 9.01B | ||
| +0.66% | -0.57% | +19.74% | +45.99% | 7.2B | ||
| +0.93% | +1.27% | +54.95% | -4.44% | 7.05B | ||
| +9.99% | +32.94% | -15.50% | +21.82% | 6.58B | ||
| +0.68% | +2.63% | +20.79% | +232.98% | 6.55B | ||
| Average | +2.05% | +3.75% | +21.96% | +76.84% | 14.57B | |
| Weighted average by Cap. | +2.07% | +3.35% | +29.39% | +89.18% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.82M 34.81M 31.99M 29.82M 56.56M 57.42M 384M 149M 1.86B 149M 146M 6.42B | 3.74B 39.32M 34.38M 31.59M 29.45M 55.85M 56.7M 379M 147M 1.84B 148M 144M 6.34B |
| Net income | 122M 1.28M 1.12M 1.03M 957K 1.81M 1.84M 12.32M 4.79M 59.8M 4.8M 4.69M 206M | 58.38M 613K 536K 493K 459K 871K 884K 5.91M 2.3M 28.7M 2.3M 2.25M 98.89M |
| Net Debt | 1.16B 12.16M 10.63M 9.77M 9.1M 17.27M 17.53M 117M 45.59M 569M 45.64M 44.66M 1.96B | 863M 9.06M 7.92M 7.28M 6.79M 12.87M 13.07M 87.43M 33.99M 424M 34.02M 33.29M 1.46B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ₹123.00 | -0.08% | 2,591 |
| 26-07-02 | ₹123.10 | -1.52% | 3,718 |
| 26-07-01 | ₹125.00 | +0.56% | 8,541 |
| 26-06-30 | ₹124.30 | -1.58% | 6,726 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















